Karachi: In a disclosure made on March 27, 2025, Citi Pharma Limited reported a transaction executed by one of its executives under the regulations of the Pakistan Stock Exchange. Asif Iqbal, an executive at the company, sold a total of 3,878 shares in the market.

The transaction was conducted through the Central Depository Company (CDC) under the ready market category. The sale took place on March 25, 2025, at a rate of 88.83 per share. This transaction resulted in a cumulative shareholding of 3,878 shares, maintaining a cumulative percentage of zero percent.

According to information available from the Pakistan Stock Exchange (PSX), the disclosure falls under the PSX Regulation 5.6.4, which mandates the reporting of share transactions by directors, CEO, executives, substantial shareholders, their spouses, and minors. This ensures transparency and accountability in the trading activities of individuals closely associated with the company.